Bristol-Myers Squibb
A news roundup for Bristol-Myers Squibb. BMS is a biopharmaceutical company based in Princeton, N.J., and offers prescription medications and biologics for diabetes, hepatitis, cancer, HIV/AIDS, cardiovascular disease, arthritis, and psychiatric disorders. It is one of the world’s largest pharmaceutical companies and had 2022 revenues in excess of $46 billion.
Latest
STAT Plus: BMS, looking to build a market for a heart drug, turns to a Viz.ai algorithm to detect disease
STAT Plus: Pharmalittle: Bristol Myers sues HHS over Medicare drug negotiations; Lilly reports new shortages of Mounjaro diabetes drug
STAT Plus: Bristol drug reduces reliance on transfusions for people with chronic blood disorder
STAT Plus: A CAR-T from Bristol Myers benefits myeloma patients at earlier stage of care
STAT Plus: The Supreme Court will review a contentious Amgen patent case, but not one involving Bristol. Why?
STAT Plus: Klobuchar, Porter call for FTC to investigate price hikes by Janssen, Bristol Myers Squibb